NAD+ is real biochemistry with a real supplement market attached to it. Here is what the human trials actually show, what the label words mean, and where the regulators currently stand — read on 10 September 2026.
Some brands we cover are clients of our publisher. What we recommend is decided by our editors, and prices are read on the date noted in each article. Our standards.
The quick take
- NAD is a coenzyme, not a stimulant. More than 400 enzymes need it, more than for any other vitamin-derived molecule, according to the NIH Office of Dietary Supplements niacin fact sheet.
- Oral precursors do raise blood NAD. That part is well replicated. Whether the increase produces the energy, endurance and “healthy aging” outcomes the category advertises is far less settled.
- NR and NMN are not in the same regulatory position. FDA has taken the view that beta-nicotinamide mononucleotide is excluded from the dietary supplement definition, while nicotinamide riboside ingredients have gone through new dietary ingredient notifications.
- Price per day is the number to compare, not price per bottle. On today’s listings the spread is roughly $1.30 to $2.20 a day for name-brand single-ingredient products.
- Read the disclaimer. Everything in this category is structure/function language under 21 CFR 101.93. None of it is a treatment claim, and none of it should be read as one.
What NAD+ actually is
Nicotinamide adenine dinucleotide is the molecule your cells use to move electrons around. It is the currency of the reactions that turn food into ATP, and it is consumed by two families of enzymes that get a lot of attention in aging research: the sirtuins and the PARPs, which are involved in DNA repair. Your body makes it from ordinary vitamin B3 — nicotinic acid and nicotinamide — and from the amino acid tryptophan. The ODS fact sheet is blunt about how little you need for basic adequacy: the adult RDA is expressed in niacin equivalents, where 1 NE is 1 mg of niacin or 60 mg of tryptophan.
So nobody buying an NAD+ supplement in 2026 is treating a deficiency. The premise of the category is different: that tissue NAD declines with age and metabolic stress, and that flooding the system with a precursor pushes levels back up. The first half of that premise has good preclinical support. The second half is where the shopping decision lives.
Editors’ note. We have not run a laboratory trial of these products and we do not claim to have. This is an explainer built from the published human literature, from federal regulatory records, and from label and price data read directly off each brand’s own product page on the date above. Nothing here is medical advice, and NAD precursors interact with the rest of your medicine cabinet in ways only your clinician can weigh. See how we choose.
What the human research supports
Three review papers are worth knowing if you are going to spend money here.
The most useful for a shopper is Damgaard and Treebak’s 2023 Science Advances paper, “What is really known about the effects of nicotinamide riboside supplementation in humans”. Its framing tells you where the field is: oral nicotinamide riboside reliably raises whole-blood NAD at doses from a few hundred milligrams up to 1,000–2,000 mg a day, and the trials that go looking for downstream metabolic benefit in humans mostly come back small, mixed, or null. Raising a biomarker is not the same as changing an outcome.
A 2023 review in the Journals of Gerontology, “Dietary Supplementation With NAD+-Boosting Compounds in Humans”, reaches a similar conclusion in more measured language: supplementation with these compounds appears safe and tolerable in the trials done so far and can increase NAD abundance, with the clinical significance still to be established. Safe and tolerable is a genuine finding, and it is the honest reason a curious person might try one. It is not the same finding as effective.
The third is a 2024 systematic review and meta-regression in Nutrition & Metabolism on glucose metabolism, C-reactive protein and liver enzymes after NAD precursor intake. If you have ever seen a marketing page imply that a B3 derivative fixes your metabolic panel, this is the paper to read before believing it.
Our reading: the evidence supports “this raises a measurable cofactor and appears well tolerated.” It does not yet support “this will make you feel different.”
NR, NMN, niacinamide: the label words
Nicotinamide riboside (NR) is the form with the largest human trial base and the clearest regulatory paper trail. It is usually sold as a branded ingredient and appears repeatedly in FDA’s public list of submitted 75-day new dietary ingredient notifications — notification 1420, for a beta-nicotinamide riboside citrate, was filed in July 2025.
Nicotinamide mononucleotide (NMN) sits one step closer to NAD in the pathway and is the ingredient most likely to appear on a longevity brand’s front page. It is also the ingredient in an unresolved regulatory fight. FDA’s position, set out in responses to notifications and restated in its 2025 answer to a citizen petition from the Natural Products Association and the Alliance for Natural Health, is that NMN is excluded from the definition of a dietary supplement because it was authorised for investigation as a new drug. Notifications keep arriving anyway — number 1444, for beta-NMN from Effepharm, was filed in November 2025 — and NMN products remain widely sold. What that means practically: an NMN product is not doing something illegal to your body, but its market position depends on an interpretation FDA has so far declined to reverse, and a formula that includes both precursors is less exposed than one that rests on NMN alone.
Plain niacinamide and nicotinic acid are the cheap versions of the same vitamin, and they are also the forms with a Tolerable Upper Intake Level attached. If a product’s differentiator is “it’s B3, but expensive,” the reason had better be the delivery form or the third-party testing.
How to compare products without getting spun
- Read the dose per day, not per capsule
- Decide whether you want a stack or a single ingredient
- Look for third-party certification
- Do the cost-per-day arithmetic
- Check the claim language against the disclaimer
The five checks
1. Dose per day, not per capsule
Serving sizes in this category range from one capsule to four, and the headline milligram number on the front of the bottle is often the daily total, not the per-capsule amount. Thorne’s NiaCel 400 is the simple case: $74 for 60 capsules, one capsule daily, which is a two-month supply and about $1.23 a day. Life Extension’s NAD+ Cell Regenerator lists at $40.50 for 30 vegetarian capsules at 300 mg — a month, at $1.35 a day. Both are single-precursor products, easy to compare precisely because their labels are boring.
2. Stack or single ingredient
A single-ingredient product is easier to evaluate and easier to stop. A stack is more convenient and harder to attribute anything to; if you buy one, ask whether every ingredient has a rationale beyond decorating the label.
Our publisher’s client MetaboLUXE lists its NAD+ capsule at $39.99 for 60 capsules, two a day with food, so a 30-day supply at $1.33 a day. Its label discloses NMN 250 mg and NR 150 mg — both precursor pathways, which is the more defensible way to build this kind of formula — plus resveratrol 100 mg, CoQ10 50 mg, L-tryptophan 100 mg and BioPerine 5 mg. The brand positions it around GLP-1 protocols and also sells a two-product berberine-and-NAD bundle at $64.98. We would read those energy and fatigue claims as the structure/function marketing they legally are: the fatigue many people report on rapid weight loss has several plausible causes, and no capsule has been shown in a trial to be the fix.
3. Third-party certification
Certification does not tell you a product works. It tells you the contents match the label and, in the sport programmes, that the batch was screened for banned substances. Thorne’s NiaCel 400 page carries NSF Certified for Sport, which is the strongest routine signal available in this category and matters most to anyone who gets drug tested. Where no certificate exists, per-batch documentation is the next best thing; neither is a lot to ask you to trust.
4. Cost per day, including the subscription trap
List price and the price you will actually pay diverge sharply here. Elysium’s Basis is $65 for a single one-month pouch today, $50 a month on a monthly subscription, and $40 a month if you prepay a year at $480 — the same product at $2.17, $1.67 or $1.33 a day depending only on how much commitment you sign. Powders shift the arithmetic again: Renue By Science lists 100 g of NMN pure powder at $54.95 and its liposomal NMN capsules at $64.95 today, and bulk powder is the cheapest way into the category for anyone comfortable weighing doses. Tru Niagen’s 300 mg line shows the same volume logic: $49 for 30 servings, $127 for 90, $244 for 180.
5. Claim language versus the disclaimer
Every product above carries some version of “this statement has not been evaluated by the Food and Drug Administration; this product is not intended to diagnose, treat, cure or prevent any disease.” That sentence is required by 21 CFR 101.93 whenever a supplement makes a structure/function claim, and it is the tell for how much a page is allowed to promise. “Supports cellular energy production” is a structure/function claim. “Reverses aging” is not a claim anyone is allowed to make about a supplement, and seeing it is a reason to close the tab.
So should you buy one?
If you want the honest version: NAD precursors are among the better-behaved longevity supplements — a real mechanism, a decent safety record in trials, and a biomarker that visibly moves. They are also a category where the marketing has run several years ahead of the outcome data, and where the same milligrams can cost you $1.30 or $2.20 a day depending on nothing but packaging and commitment.
Pick the form with the trial base you find convincing, take the certification when it is offered, buy the smallest quantity that lets you try it, and judge it against the modest claim on the label rather than the promise in the ad. If you are on prescription medication — GLP-1 agonists very much included — clear it with your prescriber first. Nothing in this article is a substitute for that conversation.
Prices and label details in this article were read on the brands’ own product pages on 10 September 2026 and change without notice. Spot something out of date? See our corrections policy.
